Tags

Type your tag names separated by a space and hit enter

[Buflomedil and nicergoline in the targeted treatment of acute cerebral ischemia. Randomized comparative double blind study].
Minerva Med 1985; 76(21):1005-18MM

Abstract

Acute cerebral ischaemia may take considerable advantages of an adequate intensive therapy associated with a specific treatment of cerebral oedemas, especially in terms of mortality-rate reduction. Moreover, target treatment of acute cerebral ischaemia may produce excellent results in severe cases selected by means of EEG-chronospectrography. Double-blind, randomized comparison between nicergolin and buflomedil especialls showed that the latter reduces mortality three times as much as nicergolin, and leads to a 200% increment in the complete recovery of the "functio laesa", limited to those cases, which showed an appreciable improvement following EEG-chronospectrographical survey.

Authors

No affiliation info available

Pub Type(s)

Clinical Trial
Comparative Study
English Abstract
Journal Article
Randomized Controlled Trial

Language

ita

PubMed ID

3889723

Citation

Bossi, L. "[Buflomedil and Nicergoline in the Targeted Treatment of Acute Cerebral Ischemia. Randomized Comparative Double Blind Study]." Minerva Medica, vol. 76, no. 21, 1985, pp. 1005-18.
Bossi L. [Buflomedil and nicergoline in the targeted treatment of acute cerebral ischemia. Randomized comparative double blind study]. Minerva Med. 1985;76(21):1005-18.
Bossi, L. (1985). [Buflomedil and nicergoline in the targeted treatment of acute cerebral ischemia. Randomized comparative double blind study]. Minerva Medica, 76(21), pp. 1005-18.
Bossi L. [Buflomedil and Nicergoline in the Targeted Treatment of Acute Cerebral Ischemia. Randomized Comparative Double Blind Study]. Minerva Med. 1985 May 19;76(21):1005-18. PubMed PMID: 3889723.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Buflomedil and nicergoline in the targeted treatment of acute cerebral ischemia. Randomized comparative double blind study]. A1 - Bossi,L, PY - 1985/5/19/pubmed PY - 1985/5/19/medline PY - 1985/5/19/entrez SP - 1005 EP - 18 JF - Minerva medica JO - Minerva Med. VL - 76 IS - 21 N2 - Acute cerebral ischaemia may take considerable advantages of an adequate intensive therapy associated with a specific treatment of cerebral oedemas, especially in terms of mortality-rate reduction. Moreover, target treatment of acute cerebral ischaemia may produce excellent results in severe cases selected by means of EEG-chronospectrography. Double-blind, randomized comparison between nicergolin and buflomedil especialls showed that the latter reduces mortality three times as much as nicergolin, and leads to a 200% increment in the complete recovery of the "functio laesa", limited to those cases, which showed an appreciable improvement following EEG-chronospectrographical survey. SN - 0026-4806 UR - https://www.unboundmedicine.com/medline/citation/3889723/[Buflomedil_and_nicergoline_in_the_targeted_treatment_of_acute_cerebral_ischemia__Randomized_comparative_double_blind_study]_ DB - PRIME DP - Unbound Medicine ER -